Microbiome and immuno-metabolic dysregulation in patients with major depressive disorder with atypical clinical presentation
{{output}}
Depression is highly prevalent (6% 1-year prevalence) and is the second leading cause of disability worldwide. Available treatment options for depression are far from optimal, with response rates only around 50%. This is most likely related to a heterogeneous ... ...
